https://orcid.org/0000-0002-8213-3493
References
- Andre C, Hampe A, Lachaume P, et al. Sequence analysis of two genomic regions containing the KIT and the FMS receptor tyrosine kinase genes. Genomics. 1997;39(2):216–226.
- Furitsu T, Tsujimura T, Tono T, et al. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest. 1993;92(4):1736–1744.
- Miettinen M, Lasota J. KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol. 2005;13(3):205–220.
- Akin C, Metcalfe DD. The biology of kit in disease and the application of pharmacogenetics. J Allergy Clin Immunol. 2004;114(1):13–19; quiz 20.
- Arock M, Valent P. Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives. Expert Rev Hematol. 2010;3(4):497–516.
- Reiter A, George TI, Gotlib J. New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis. Blood. 2020;135(16):1365–1376.
- Arock M, Sotlar K, Akin C, et al. KIT mutation analysis in mast cell neoplasms: recommendations of the european competence network on mastocytosis. Leukemia. 2015;29(6):1223–1232.
- Horny HP, Metcalf DD, Bennett JM, et al. Mastocytosis. In: Swerdlow SH, Campo E, Harris NL, editors. WHO classification of tumors of hematopoietic and lymphoid tissues. Lyon: Lyon IARC Press; 2008. p. 54.
- Robey RC, Wilcock A, Bonin H, et al. Hereditary alpha-tryptasemia: UK prevalence and variability in disease expression. J Allergy Clin Immunol Pract. 2020;8(10):3549–3556.
- Lyons JJ, Yu X, Hughes JD, et al. Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number. Nat Genet. 2016;48(12):1564–1569.
- Greiner G, Sprinzl B, Górska A, et al. Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis. Blood. 2021;137(2):238–247. Jan
- Lyons JJ, Chovanec J, O'Connell MP, et al. Heritable risk for severe anaphylaxis associated with increased α-tryptase–encoding germline copy number at TPSAB1. J Allergy Clin Immunol. 2021;147(2):622–632.
- Beghini A, Larizza L, Cairoli R, et al. c-kit activating mutations and mast cell proliferation in human leukemia. Blood. 1998;92(2):701–703.
- Carrigan C, Milner JD, Lyons JJ, et al. Usefulness of testing for hereditary alpha tryptasemia in symptomatic patients with elevated tryptase. J Allergy Clin Immunol Practice. 2020;8(6):2066–2067.